Cancer News and Research

Latest Cancer News and Research

Anastomotic leakage does not increase rectal cancer recurrence risk

Incidence of clinical anastomotic leak after anterior resection for patients with rectal adenocarcinoma does not increase the risk for local disease recurrence, despite previous studies indicating the opposite, report US researchers.

30 Aug 2012

Chronic nerve pain: an interview with Professor Sally Lawson

Chronic nerve pain results from pathological changes within a nerve that appear to be self-sustaining and thus the pain continues for a long time.

30 Aug 2012

New book on medical screening to be launched on Sep. 4

Delegates from around the world will gather for the launch of a new book on medical screening edited by University of Leicester academics.

30 Aug 2012

Removing entire pancreas does not result in unmanageable diabetes in patients with cancer

Removing the entire pancreas in patients with cancer or precancerous cysts in part of the organ does not result in unmanageable diabetes — as many physicians previously believed, research at Mayo Clinic in Florida has found.

30 Aug 2012

Janssen receives FDA Priority Review for ZYTIGA sNDA to treat mCRPC

Janssen Research & Development, LLC, announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the supplemental New Drug Application (sNDA) for ZYTIGA (abiraterone acetate) administered in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy.

30 Aug 2012

New York State Department of Health issues license to Veracyte's Afirma Gene Expression Classifier

Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, and Genzyme, a Sanofi company, today announced that the New York State Department of Health has issued a license enabling Veracyte's Afirma Gene Expression Classifier to be offered to patients in the state.

30 Aug 2012

MU medicinal chemists create more potent, efficient weapon against cancer

Legend has it that Ralph Waldo Emerson once said, "Build a better mousetrap, and the world will beat a path to your door." University of Missouri researchers are doing just that, but instead of building mousetraps, the scientists are targeting cancer drugs. In a new study, MU medicinal chemists have taken an existing drug that is being developed for use in fighting certain types of cancer, added a special structure to it, and created a more potent, efficient weapon against cancer.

30 Aug 2012

University of Adelaide researchers to produce better quality pasta with health properties

University of Adelaide researchers are working with colleagues in Italy to produce better quality pasta that also adds greater value to human health.

30 Aug 2012

UTMB to offer HPV vaccination against cervical cancer

University of Texas Medical Branch at Galveston's Dr. Abbey Berenson has been awarded a $1.2 million grant to start a program that will provide a vaccination against cervical cancer to many hundreds of low-income women who receive health care services at UTMB.

30 Aug 2012

Johns Hopkins team creates synthetic protein that can help locate tumors

Johns Hopkins researchers have created a synthetic protein that, when activated by ultraviolet light, can guide doctors to places within the body where cancer, arthritis and other serious medical disorders can be detected.

30 Aug 2012

CCE, Accretive Health partner to develop novel oncology care management

Accretive Health, Inc., a healthcare technology and services company, and Cancer Clinics of Excellence (CCE), a national network of practice-owned, physician-driven community-based oncology practices, announced today that they have partnered to develop a novel, end-to-end oncology care management offering designed to enable healthcare providers to improve the efficacy and quality of cancer care while simultaneously improving the affordability of the healthcare system.

30 Aug 2012

Book guides men with prostate cancer to maintain sexual health and quality of life

Men with prostate cancer may fear that they will never have sex again. What they are feeling can be disturbing, but there is hope. Jeffrey Albaugh, PhD, APRN, CUCNS, addresses sexual issues during and after prostate cancer treatment in a new book written specifically for patients and their partners: Reclaiming Sex & Intimacy After Prostate Cancer: A Guide for Men and Their Partners.

30 Aug 2012

Genmab, Janssen partner to develop and commercialize daratumumab for multiple myeloma

Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has executed a global license and development agreement with the Danish company Genmab A/S for the anti-cancer compound, daratumumab.

30 Aug 2012

Researchers identify mechanism that explains link between trichomoniasis and prostate cancer

Researchers have identified a way in which men can develop prostate cancer after contracting trichomoniasis, a curable but often overlooked sexually transmitted disease.

30 Aug 2012

NCCN announces new guidelines for patients with pancreatic Cancer

The National Comprehensive Cancer Network (NCCN), with the support of the Pancreatic Cancer Action Network, announces the latest addition to the library of NCCN Guidelines for PatientsTM, patient-friendly translations of the NCCN Clinical Practice Guidelines in Oncology.

30 Aug 2012

Lilly decides to terminate pomaglumetad methionil Phase III trial on schizophrenia

Eli Lilly and Company announced today the decision to stop ongoing clinical studies investigating pomaglumetad methionil, also known as mGlu2/3, for the treatment of patients suffering from schizophrenia.

30 Aug 2012

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

The U.S. Food and Drug Administration today approved Sicor Biotech's tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

30 Aug 2012

CNIO team generates transgenic mouse model for aplastic anaemia associated with short telomeres

Aplastic anaemia is characterised by a reduction in the number of the bone marrow cells that go on to form the different cell types present in blood (essentially red blood cells, white blood cells and platelets). In most cases, the causes of the disorder are hard to determine, but some patients have been found to have genetic alterations leading to a shortening of their telomeres (the end regions of chromosomes that protect and stabilise DNA).

30 Aug 2012

Novartis receives FDA approval for Afinitor Disperz to treat subependymal giant cell astrocytoma

The U.S. Food and Drug Administration today approved Afinitor Disperz (everolimus tablets for oral suspension), a new pediatric dosage form of the anti-cancer drug Afinitor (everolimus) used to treat a rare brain tumor called subependymal giant cell astrocytoma.

30 Aug 2012

Roundup: Calif. Gov. Brown's pension plan silent on current workers' health care; Psychologists want power to prescribe drugs

Gov. Jerry Brown announced a new plan Tuesday to rein in public pension costs that would raise the retirement age, cap benefits for the highest-paid employees and eliminate "spiking" -- but lacks key parts of the bolder system overhaul he proposed months ago and would even increase some payouts. ... The plan also does not address skyrocketing health care costs for retirees, another main element of the governor's first scenario. Hundreds of thousands of government workers have been promised medical coverage for life.

30 Aug 2012

Cancer News and Research

Latest Cancer News and Research

Anastomotic leakage does not increase rectal cancer recurrence risk

Chronic nerve pain: an interview with Professor Sally Lawson

New book on medical screening to be launched on Sep. 4

Removing entire pancreas does not result in unmanageable diabetes in patients with cancer

Janssen receives FDA Priority Review for ZYTIGA sNDA to treat mCRPC

New York State Department of Health issues license to Veracyte's Afirma Gene Expression Classifier

MU medicinal chemists create more potent, efficient weapon against cancer

University of Adelaide researchers to produce better quality pasta with health properties

UTMB to offer HPV vaccination against cervical cancer

Johns Hopkins team creates synthetic protein that can help locate tumors

CCE, Accretive Health partner to develop novel oncology care management

Book guides men with prostate cancer to maintain sexual health and quality of life

Genmab, Janssen partner to develop and commercialize daratumumab for multiple myeloma

Researchers identify mechanism that explains link between trichomoniasis and prostate cancer

NCCN announces new guidelines for patients with pancreatic Cancer

Lilly decides to terminate pomaglumetad methionil Phase III trial on schizophrenia

Sicor Biotech receives FDA approval for tbo-filgrastim to treat severe neutropenia

CNIO team generates transgenic mouse model for aplastic anaemia associated with short telomeres

Novartis receives FDA approval for Afinitor Disperz to treat subependymal giant cell astrocytoma

Roundup: Calif. Gov. Brown's pension plan silent on current workers' health care; Psychologists want power to prescribe drugs

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in